The market for mammography equipment in South Korea is undergoing significant growth. This upsurge is attributable to the broadening scope of breast cancer screening initiatives, increased public awareness, and the incorporation of sophisticated imaging technologies. Owing to these factors, the mammography equipment market in South Korea is set to grow at a compound annual growth rate (CAGR) of approximately 4 per cent through 2036, forecasts GlobalData.
GlobalData’s latest report, “Mammography Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” reveals that South Korea represented nearly 20 per cent of the mammography equipment market in the Asia-Pacific region in 2024. This significant share highlights the country’s strong healthcare infrastructure, early embrace of new technologies, and a clear national focus on preventive healthcare and innovation.
In March 2025, a comprehensive Korean study revealed that the utilisation of Lunit INSIGHT MMG, an AI-powered mammography software developed by the South Korean medical AI firm Lunit Inc., enhanced breast cancer detection rates by 13.8 per cent without elevating recall rates. The findings affirm South Korea’s advancing role in shaping high-impact, AI-driven medical imaging practices that prioritise accuracy without added patient burden.
Shagufta Hasan, Medical Devices Analyst at GlobalData, comments, “Despite the growth of mammography market in South Korea, breast cancer detection still faces challenges related to inconsistent access, diagnostic delays, and disparities in the adoption of technology, factors that may hinder early intervention and patient outcomes. However, solutions such as the Lunit INSIGHT MMG and DBT represent a transformative shift in breast imaging. These advanced diagnostic solutions are paving the way for more detailed, efficient, and accessible screening pathways, aligning with the country’s broader commitment to preventive healthcare and innovation.”
AI solutions such as Lunit INSIGHT MMG and DBT streamline case prioritisation, support early diagnosis, and enhance precision across diverse clinical environments. By reducing diagnostic delays and standardising interpretation regardless of reader experience, these solutions help bridge gaps in access and technological disparities, ultimately supporting more equitable breast cancer screening outcomes.
Hasan concludes, “South Korea appears to be strategically poised to influence the future of breast imaging through continued investment, fostering strategic partnerships, and expanding its global outreach. By reinforcing its position in the advancement of diagnostic technologies, it is likely to enhance access to high-quality care to patients with breast cancer, and bolster its global impact.”